Carlos Alvear Lopez · 66-41 · MEXICO
For Carlos Alvear Lopez · 66-41 · MEXICO, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is MEXICO; product is Diabetless Plus (powder or capsule) | Diabetless Plus (powder or capsule); product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/17/2022; address is Domicilio Conocido S/N , Jalmolonga Malinalco, Mexico MEXICO, verified against its source on 2026-09-16.
- Firm
- Carlos Alvear Lopez verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- MEXICO verified
- Address
- Domicilio Conocido S/N , Jalmolonga Malinalco, Mexico MEXICO verified
- Date published
- 06/17/2022 verified
- Product code
- 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Diabetless Plus (powder or capsule) | Diabetless Plus (powder or capsule) each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’. each item verified
What the source says
Carlos Alvear Lopez Date Published : 06/17/2022 Domicilio Conocido S/N , Jalmolonga Malinalco, Mexico MEXICO 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 06/17/2022 Desc: Diabetless Plus (powder or capsule) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/17/2022 Desc: Diabetless Plus (powder or capsule) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.